ICAGEN, INC. STOCKHOLDER WAIVER, AMENDMENT AND TERMINATION AGREEMENT
Exhibit 4.1
ICAGEN, INC.
STOCKHOLDER
WAIVER, AMENDMENT AND TERMINATION AGREEMENT
WHEREAS, Icagen, Inc., a Delaware corporation (the Company), and certain stockholders of the Company are parties to the Amended and Restated Stockholders Agreement dated as of April 16, 2004 (the Stockholders Agreement) setting forth certain rights with respect to the registration of their shares of common stock, $0.001 par value per share (the Common Stock), of the Company under the Securities Act of 1933, as amended (the Securities Act);
WHEREAS, over two years have passed since the completion of the Companys initial public offering of shares of Common Stock in February 2005, making certain of the agreements in the Stockholders Agreement unnecessary, burdensome or inappropriate for stockholders of a public company; and
WHEREAS, except for affiliates of the Company, the parties to the Stockholders Agreement are eligible to sell their shares of Common Stock that are the subject of the Stockholders Agreement in reliance on Rule 144(k) of the Securities Act.
NOW, THEREFORE, the undersigned, representing the holders of at least 70% of the Registrable Securities (as defined in the Stockholders Agreement) then held by the Holders (as defined in the Stockholders Agreement) whose registration rights have not expired pursuant to Section 2.15 of the Stockholders Agreement do hereby agree, pursuant to and in accordance with Section 4.3 of the Stockholders Agreement, as follows:
1. Stockholders Agreement. The undersigned hereby approves of the termination of or amendment to the following provisions of the Stockholders Agreement:
(i) Section 2.2(a) of the Stockholders Agreement be amended in its entirety and restated to read as follows:
Request for Registration. If the Company shall determine to file a registration statement with respect to any of its securities either for its own account or the account of a security holder or holders (other than with respect to a registration statement filed pursuant to the Companys initial public offering; a registration statement filed pursuant to Section 2.1, 2.3 or 2.4 hereof; a shelf registration statement; or a registration statement covering shares to be sold solely for the account of another holder or holders, which shares were acquired pursuant to either (A) an acquisition of a company of which they were formerly stockholders, (B) a private placement under the Securities Act or (C) Rule 144A under the Securities Act) at any time and from time to time, the Company will, prior to the filing of such registration statement:
(i) promptly give to each Holder written notice thereof advising them of their right to join in such registration; and
(ii) use its best efforts to include in such registration, except as set forth in Section 2.2(b) below, and in any underwriting involved therein, all the Registrable Securities specified in a written request or
requests, made by any Holder within twenty (20) days after the written notice from the Company described in clause (i) above is effective (which request shall state the intended method of disposition of such Registrable Securities) to the extent necessary to permit their sale or other disposition in accordance with the intended method of distribution specified in the request of such Holder. Such written request may specify all or a part of a Holders Registrable Securities. Notwithstanding the foregoing: (i) the Company shall have the right to postpone or withdraw any registration effected pursuant to this Section 2.2 without obligation to any Holder and (ii) the rights of this Section 2.2 shall not apply with respect to registration statements filed in connection with the Companys initial public offering.
(ii) Section 2.11(a) of the Stockholders Agreement be and hereby is terminated.
(iii) Section 2.15 of the Stockholders Agreement be amended in its entirety and restated to read as follows:
All of the Companys obligations to register Registrable Securities pursuant to this Agreement shall terminate with respect to a particular Holder on the earlier to occur of (A) December 15, 2009 or (B) the date all shares of Registrable Securities held by such Holder may be sold pursuant to Rule 144(k).
2. Waiver of Notice. The undersigned hereby waives any notice to which the undersigned may be entitled, in the undersigneds capacity as a stockholder or otherwise, of any agreement contemplated by this Stockholder Waiver, Amendment and Termination Agreement.
3. Effectiveness. The undersigned hereby agrees that this Stockholder Waiver, Amendment and Termination Agreement shall be effective for all purposes upon receipt by the Company or its counsel of signed signature pages of this Stockholder Waiver, Amendment and Termination Agreement (or a facsimile thereof) representing the requisite stockholder consents referred to above, and that the Company is authorized to attach such signed signature pages to the pages comprising the balance of this Stockholder Waiver, Amendment and Termination Agreement.
The undersigned further agrees that the agreements herein are severable, so that in the event any transaction contemplated by one waiver, amendment or termination does not occur, the other waivers, amendments and terminations shall remain effective.
This Stockholder Waiver, Amendment and Termination Agreement may be executed in one or more counterparts.
- 2 -
IN WITNESS WHEREOF, the undersigned has executed this Stockholder Waiver, Amendment and Termination Agreement as of the date set forth below.
COMPANY: | ||||||||
ICAGEN, INC. | ||||||||
Dated: July 10, 2007 | By: | /s/ P. Kay Wagoner | ||||||
Name: | P. Kay Wagoner, Ph.D. | |||||||
Title: | President and Chief Executive Officer | |||||||
STOCKHOLDERS: | ||||||||
Dated: May 29, 2007 | By: | /s/ Jean Deleage | ||||||
Name: | Jean Deleage | |||||||
Dated: May 24, 2007 | By: | /s/ Juerg Geigy | ||||||
Name: | Juerg Geigy | |||||||
Dated: June 5, 2007 | By: | /s/ Sheikh Isam K. Kabbani | ||||||
Name: | Sheikh Isam K. Kabbani | |||||||
Dated: July 10, 2007 | By: | /s/ André L. Lamotte | ||||||
Name: | André L. Lamotte | |||||||
AL-MIDANI INVESTMENT COMPANY, LTD. | ||||||||
Dated: June 4, 2007 | By: | /s/ M. N. ALMIDANI | ||||||
Name: | M. N. ALMIDANI | |||||||
Title: | DIRECTOR | |||||||
ALTA BIOPHARMA PARTNERS, L.P. | ||||||||
Dated: May 31, 2007 | By: | Alta BioPharma Management, LLC | ||||||
By: | /s/ Alix Marduel | |||||||
Name: | Alix Marduel | |||||||
Title: | Managing Director |
- 3 -
ALTA EMBARCADERO BIOPHARMA PARTNERS, LLC | ||||||||
Dated: May 31, 2007 | By: | /s/ Hilary Strain | ||||||
Name: | Hilary Strain | |||||||
Title: | Under Power of Attorney | |||||||
ELI LILLY AND COMPANY | ||||||||
Dated: May 25, 2007 | By: | /s/ James B. Lootens | ||||||
Name: | James B. Lootens | |||||||
Title: | Secretary | |||||||
FINOVE, LTD. | ||||||||
Dated: June 8, 2007 | By: | /s/ CHRISTOPHER LE BOUTILLIER | ||||||
Name: | CHRISTOPHER LE BOUTILLIER | |||||||
Title: | DIRECTOR | |||||||
GUTRAFIN LTD. | ||||||||
Dated: May 25, 2007 | By: | /s/ Francis C. Lang | ||||||
Name: | Francis C. Lang | |||||||
Title: | Senior Investment Representative | |||||||
HØEGH INVEST AS | ||||||||
Dated: May 22, 2007 | By: | /s/ Carl Preben Høegh | ||||||
Name: | Carl Preben Høegh | |||||||
Title: | Senior Partner | |||||||
FRED D. HUTCHISON AND NANCY HUTCHISON, TEN COM | ||||||||
Dated: July 5, 2007 | By: | /s/ Fred D. Hutchison | ||||||
Name: | Fred D. Hutchison, individually and as Attorney in Fact for Nancy L. Hutchinson |
- 4 -
ICAGEN CHASE PARTNERS (ALTA BIO), LLC | ||||||||
Dated: May 31, 2007 | By: | Alta/Chase BioPharma Management, LLC | ||||||
By: | /s/ Alix Marduel | |||||||
Name: | Alix Marduel | |||||||
Title: | Member | |||||||
PHARMABIO DEVELOPMENT INC. d/b/a NOVAQUEST | ||||||||
Dated: May 22, 2007 | By: | /s/ Kerry E. Zook | ||||||
Name: | Kerry E. Zook | |||||||
Title: | V.P., General Counsel | |||||||
SELECTRA INVESTMENT & MANAGEMENT II, INC. | ||||||||
Dated: May 25, 2007 | By: | /s/ F. C. Lang | ||||||
Name: | F. C. Lang | |||||||
Title: | Chairman & CEO | |||||||
TRIANGLE SECURITIES AS C/F FRED D. HUTCHISONIRA | ||||||||
Dated: July 5, 2007 | By: | /s/ Fred D. Hutchison | ||||||
Name: | Fred D. Hutchison, Beneficiary | |||||||
VENROCK ASSOCIATES | ||||||||
Dated: May 23, 2007 | By: | /s/ Anthony B. Evnin | ||||||
Name: | Anthony B. Evnin | |||||||
Title: | General Partner | |||||||
VENROCK ASSOCIATES II, L.P. | ||||||||
Dated: May 23, 2007 | By: | /s/ Anthony B. Evnin | ||||||
Name: | Anthony B. Evnin | |||||||
Title: | General Partner |
- 5 -
XANTHUS LIMITED | ||||||||
Dated: June 1, 2007 | By: | /s/ R.M. Falla /s/ G.R. Le Page | ||||||
Name: | R.M. Falla and G.R. Le Page | |||||||
Title: | Directors | |||||||
ZIAD ZEIN EL ABDIN CORPORATION | ||||||||
Dated: June 20, 2007 | By: | /s/ Hounada Mukhtar Mohd Diab | ||||||
Name: | Hounada Mukhtar Mohd Diab | |||||||
Title: | Wife of Ziad Zein El Abdin |
- 6 -